Treatment for Myeloproliferative Disorders

MPN News and Updates From ASCO 2017

As part of our coverage from the 2017 American Society of Clinical Oncology annual meeting, Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center provides a hopeful update for patients living with MPNs.

Published:

Why Are My Neutrophils and Platelets Monitored So Closely?

Why are your neutrophils and platelets are monitored so closely? Learn more from Dr. William Wierda and Dr. Susan Leclair.

Published:

What Is a CBC Test and Why Did Your Doctor Order It?

Learn more about CBCs, including what your doctor is looking for and how the information is gathered in the lab. With Drs. William Wierda and Susan Leclair.

Published:

Webinar Replay: Understanding and Interpreting Complete Blood Count (CBC) Results

Watch the replay of our virtual webinar, as Patient Power founder Andrew Schorr leads a panel of experts, including Dr. William Wierda, Dr. Susan Leclair and Lynn Ingram, in a discussion on the meanings of lab test results in easy-to-understand terms.

Published:

How Do I Avoid Neuropathy As a Treatment Side Effect?

Dr. Prithviraj Bose from The University of Texas MD Anderson Cancer Center responds to a member question about peripheral neuropathy as a side effect of treatment for essential thrombocythemia (ET).

Published:

Expert Perspective: Understanding Precision Medicine

From the 2017 ASCO Survivorship Symposium, Dr. Angela Bradbury joined Patient Power to help viewers to explain the role precision medicine in cancer treatment today.

Published:

Pharmacist’s Perspective: Understanding Dosing, Adherence and Drug Interactions

At a recent MPN town meeting, Dr. Jigar Trivedi, a pharmacist at Carolinas HealthCare System's Levine Cancer Institute, shared insight for patients.

Published:

Making Sense of Precision Medicine Test Results

Learn more about personalized medicine, also known as precision medicine, in this web interview with Patient Power Host Andrew Schorr and Dr. Razelle Kurzrock, Director of the Center for Personalized Cancer Therapy at UC San Diego.

Published:

What Does the Future Hold for MPNs? Experts Weigh In

At ASH 2016, MPN experts from across the nation share their perspective on what the future holds for MPNs, in both the short term and long term.

Published:

Showing 9 of 225 programs

Page last updated on October 19, 2015